Pharmacogenetic studies in Alzheimer disease

Introduction: Alzheimer disease (AD) is the most common cause of dementia and is considered one of the main causes of disability and dependence affecting quality of life in elderly people and their families. Current pharmacological treatment includes acetylcholinesterase inhibitors (donepezil, galan...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: T. Zúñiga Santamaría, P. Yescas Gómez, I. Fricke Galindo, M. González González, A. Ortega Vázquez, M. López López
Formato: Artigo
Idioma:Inglês
Publicado: Elsevier España 2022-05-01
Series:Neurología (English Edition)
Assuntos:
Enfermedad de Alzheimer
Farmacogenética
Inhibidores de acetilcolinesterasa
APOE
CYP2D6
ABCB1
Acceso en liña:http://www.sciencedirect.com/science/article/pii/S2173580820300882
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares